REQUEST A DEMO
Total
USD $0.00
Search more companies

Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alar Pharmaceuticals Inc. Profile Updated: January 27, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) is an enterprise in Taiwan, China, with the main office in Taichung City. It operates in the Pharmaceutical and Medicine Manufacturing industry. Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) was incorporated on September 23, 2016. 27 (2024) employees currently work for Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司). From the latest financial highlights, Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) reported a net sales revenue drop of 78.46% in Q3C2025. There was a total negative growth of 0.29% in Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司)’s total assets over the same period. The net profit margin of Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) decreased by 4213.18% in 2025.

Headquarters
5F., No.32, Keya Rd., Daya Dist
Taichung City; Taichung City;

Contact Details: Purchase the Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) report to view the information.

Website: http://www.alarpharm.com

Basic Information
Total Employees:
Purchase the Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) report to view the information.
Incorporation Date:
September 23, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
10.55%
Purchase this report to view the information.
10.2%
Purchase this report to view the information.
8.21%
Purchase this report to view the information.
5.27%
Purchase this report to view the information.
4.49%
Company Performance
Financial values in the chart are available after Alar Pharmaceuticals Inc. (昱展新药生技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-78.46%
Total Operating Revenue
10.94%
Operating Profit
-109.42%
EBITDA
-113.82%
Net Profit/Loss for the Period
-708.06%
Total Assets
-0.29%
Total Equity
-1.87%
Operating Profit Margin
-8031.61%
Net Profit Margin
-4213.18%
Return on Equity (ROE)
-1.97%
Debt / Equity
167%
Quick Ratio
-18644.73%
Cash Ratio
2.84%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?